CYP2R1 Genotype

Some people stay vitamin D deficient no matter how much sun they get or how many capsules they swallow. A meaningful share of that variation comes from a single gene called CYP2R1 (cytochrome P450 family 2 subfamily R member 1), which makes the main liver enzyme responsible for the first activation step that turns vitamin D into the form your blood test actually measures.

Testing CYP2R1 once tells you whether you inherited common or rare changes in this gene that lower your baseline vitamin D, blunt your response to supplements, and have been tied to specific disease risks. It is a one-time read on a permanent piece of your biology.

What CYP2R1 Actually Does

Vitamin D from sun or food is biologically inactive until your liver attaches a chemical tag to it. CYP2R1 builds the main enzyme that performs that tagging step, producing 25-hydroxyvitamin D, abbreviated 25-OH-D, which is the form circulating in your blood and what every standard vitamin D test measures. A separate kidney enzyme then performs a second activation to make the fully active hormone.

CYP2R1 is the main, but not the only, enzyme that performs this step. Other enzymes such as CYP27A1 also contribute, and animal studies show that even complete loss of CYP2R1 still leaves more than half of normal 25-OH-D production intact. For people with common reduced-activity variants, the effect on vitamin D levels is real but modest, while two damaged copies of CYP2R1 create a much more serious bottleneck. The enzyme is expressed most strongly in the liver but is also found in the testes, kidney, brown fat, and many other tissues.

Rare Severe Variants and Inherited Rickets

Carrying two damaged copies of CYP2R1 causes a specific genetic form of vitamin D deficiency called vitamin D-dependent rickets type 1B, often shortened to VDDR1B. People with this condition show very low 25-OH-D, normal or even high levels of the fully active form, low calcium, low phosphate, and skeletal abnormalities such as bowed legs in childhood. Reported pathogenic changes include variants known as L99P and K242N, identified in case series of families with severe rickets.

Even carrying only one damaged copy can blunt 25-OH-D levels modestly and weaken the response to oral vitamin D, a pattern researchers describe as semi-dominant inheritance with dosage-dependent effects. Researchers describing this pattern argue that VDDR1B is regularly mistaken for ordinary nutritional deficiency, which means a CYP2R1 result can change how unexplained, treatment-resistant deficiency is interpreted.

Common Variants and Baseline Vitamin D

Most of CYP2R1 testing is not about rare rickets-causing mutations. It is about common single-letter changes in the gene, called SNPs (single-nucleotide polymorphisms, the most common kind of genetic variation between people). Variants such as rs10741657, rs2060793, rs10766197, and rs12794714 have been linked across multiple populations to lower circulating 25-OH-D.

In one study of 180 family practice patients, carrying the variant alleles of rs10741657 was tied to roughly 3.7 times higher odds of being vitamin D deficient. Larger meta-analyses have found more modest pooled odds ratios closer to 1.1 to 1.4 depending on the genetic model, so the 3.7 figure should be read as one estimate from a smaller study rather than the consensus effect size. A separate genome-wide study of about 79,000 adults of European ancestry confirmed CYP2R1 as one of the strongest genetic signals shaping 25-OH-D levels across the general population.

What this means for you: if your vitamin D consistently runs low even when you spend time outside and take a typical dose, CYP2R1 variants are one of the few testable genetic explanations. They do not change your need for vitamin D, but they help explain why your number is what it is.

Multiple Sclerosis Risk

A pooled analysis combining genetic data from large cohorts identified a low-frequency change in CYP2R1, rs117913124, that has a large effect on 25-OH-D. Carriers were roughly 2.2 times more likely to have vitamin D insufficiency and about 1.4 times more likely to develop multiple sclerosis in the general European population. Common CYP2R1 SNPs have also been associated with MS in separate Jordanian and European cohorts, and Mendelian randomization analyses broadly support a causal role for vitamin D in MS, in contrast to many other diseases.

Type 1 Diabetes

In a German study of 609 people, CYP2R1 polymorphisms were linked to both lower vitamin D levels and increased susceptibility to type 1 diabetes. A separate analysis of more than 24,000 people across multiple cohorts found that inherited variation in CYP2R1 and a related vitamin D gene was consistently associated with higher type 1 diabetes risk. This is associative evidence rather than proof of causation, but it supports a genetic role for vitamin D in this autoimmune condition.

Recurrent Pregnancy Loss

A case-control study of 158 women linked the CYP2R1 variant rs12794714 to both lower serum vitamin D and increased odds of recurrent spontaneous miscarriage. The authors suggested that genotyping pregnant women for this variant could support earlier counseling and supplementation decisions, though no trial has yet confirmed that acting on the result changes outcomes.

Cardiovascular and Metabolic Patterns

In a study of 766 people, CYP2R1 rs10741657 was identified as a potential genetic risk marker for cardiovascular disease. A smaller pilot of 53 cardiovascular patients found that CYP2R1 polymorphisms helped shape vitamin D metabolite patterns in that group. CYP2R1 variation has also been studied alongside vitamin D receptor and binding protein variants in metabolic syndrome cohorts.

Counterintuitively, when researchers use CYP2R1 variants as a long-term proxy for lifelong lower vitamin D, the genetically driven low levels do not clearly cause heart attacks, ischemic heart disease, or in most analyses type 2 diabetes. This does not mean your genotype is meaningless. It means the link between low vitamin D and these specific diseases is partly explained by factors other than vitamin D itself, such as obesity and inflammation, which is why your CYP2R1 result is best treated as a piece of context rather than a verdict on heart or metabolic risk.

Response to Vitamin D Supplementation

A randomized trial of 1,787 adults found that CYP2R1, CYP24A1, and vitamin D receptor genotypes modify how much 25-OH-D rises in response to vitamin D3 supplementation. Another study in 253 adults reported that carriers of the common G allele at the CYP2R1 variant rs10766197 had greater vitamin D rises on supplementation than non-carriers.

In Tunisian adults with deficiency, the variants rs10766197 and rs12794714 were tied to lower likelihood of correcting deficiency with standard dosing. A study in 293 Danish adults found that CYP2R1 SNPs influenced how much 25-OH-D rose after both UVB light exposure and six months of vitamin D3-fortified food.

What this means for you: if your CYP2R1 genotype is in a slower-responding category, you may need a higher dose, longer duration, or both to reach the same blood level that someone else achieves on standard amounts. Tracking your 25-OH-D over time becomes the practical readout, not retesting your gene.

Population Patterns and Ancestry

A survey of 44 CYP2R1 variants found that many reduce enzyme activity, and that lower-activity versions tend to be more common in populations from equatorial regions with abundant sunlight. The interpretation is that strong UVB exposure made high enzyme activity less necessary, so reduced-activity variants accumulated. The practical implication is that the clinical meaning of a specific CYP2R1 result depends partly on ancestry, because the allele frequency differs across populations.

When Results Can Be Misleading

• Variant panel coverage: the assay only reports the specific variants it is designed to detect. A negative result rules out the listed variants, not every possible change in the gene. Rare or family-specific mutations can be missed.
• Ancestry effects: some CYP2R1 variants are common in one population and rare in another, so the practical meaning of a given result depends on your background. A variant flagged as significant in European cohorts may have a different frequency and effect in African, East Asian, or Middle Eastern populations.
• Variants of uncertain significance: if the panel reports a less-studied change, the clinical meaning may be unknown. This is not a lab error, it reflects the current state of evidence.
• Direct-to-consumer vs clinical-grade testing: consumer reports of vitamin D-related variants are often based on a single SNP and may not match the breadth or accuracy of a clinical-grade genotyping assay.

One-Time Result, Lifetime Use

Your CYP2R1 genotype is set at conception and does not change. There is no benefit to repeating the genetic test itself, unless a confirmatory method is needed to verify an unexpected call. The value of the test is what it tells you about how to interpret and act on your dynamic vitamin D testing for the rest of your life.

What does need ongoing tracking is 25-OH-D, which responds to season, supplementation, weight changes, and liver health. A reasonable cadence is a baseline 25-OH-D test, a recheck three to six months after starting or changing a supplement regimen, and at least annually thereafter, with calcium and parathyroid hormone added if levels run unusually high or low.

Decision Pathway for an Unexpected Result

If your CYP2R1 result flags a known reduced-activity variant, the first step is not retesting the gene but adding companion tests that show what is happening downstream. Order 25-OH-D, calcium, phosphate, and intact parathyroid hormone. If your 25-OH-D is low despite reasonable supplementation, an endocrinologist familiar with vitamin D metabolism can help interpret patterns and adjust dosing.

If your panel identifies a rare loss-of-function variant consistent with VDDR1B, especially in the setting of unexplained skeletal symptoms or treatment-resistant deficiency, a referral to an endocrinologist and a genetic counselor is appropriate. Treatment for confirmed CYP2R1 deficiency typically involves giving 25-hydroxyvitamin D (calcifediol) directly, bypassing the broken enzyme, rather than ordinary vitamin D2 or D3.

For more common variants tied to modestly lower vitamin D or higher autoimmune risk, the decision pathway is mostly about vigilance. Use your genotype as a reason to track vitamin D more carefully, address modifiable risks like obesity that further suppress the same enzyme, and treat your supplementation plan as something to monitor rather than set once and forget.

What This Result Means for Your Family

Because CYP2R1 variants are inherited, your result has implications for biological parents, siblings, and children. Each first-degree relative has roughly a fifty percent chance of carrying any given variant you have. If your result identifies a rare deficiency-causing variant, sharing the finding lets relatives decide whether to test themselves, especially if they have unexplained bone pain, low vitamin D, or children with growth concerns.